Real-world insights into treatment modalities and emerging myosin inhibitor therapy for hypertrophic obstructive cardiomyopathy: early findings from the German REDUCE-Registry

Back

ESC2025 Premium Access

Real-world insights into treatment modalities and emerging myosin inhibitor therapy for hypertrophic obstructive cardiomyopathy: early findings from the German REDUCE-Registry

Session: Left ventricular outflow tract obstruction

Topic: Hypertrophic Cardiomyopathy

Speaker: Doctor L. Seuthe (Cologne, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Leni Katharina Seuthe

Cologne University Hospital - Heart Center, Cologne (Germany)

1 presentation

0 follower

6 more presentations in this session

Multicenter study on the effect of Mavacamten on pulmonary artery systolic pressure derived from echo-doppler in obstructive hypertrophic cardiomyopathy

Speaker: Doctor M. Gegenava (Tbilisi, GE)

Comparison of characteristics and outcomes of patients with obstructive vs. non-obstructive hypertrophic cardiomyopathy in a cohort from a referral center in colombia

Speaker: Doctor J. Orozco Burbano (Medellin, CO)

Outcomes of alcohol septal ablation for obstructive hypertrophic cardiomyopathy in Japan

Speaker: Doctor T. Yamaguchi (Tokyo, JP)

Genetic, echocardiographic and clinical determinants of mitral valve abnormalities in hypertrophic cardiomyopathy

Speaker: Miss H. Panholzer (Graz, AT)

Common pathophysiological mechanism of SAM and mitral regurgitation in HOCM

Speaker: Associate Professor Z. Wang (Hangzhou, CN)

Access the full session

Left ventricular outflow tract obstruction

Speakers: Doctor L. Seuthe, Doctor M. Gegenava, Doctor J. Orozco Burbano, Doctor T. Yamaguchi, Miss H. Panholzer...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources